Medication Self-Management in Hospitalised Patients with Schizophrenia or Bipolar Disorder: The Perceptions of Patients and Healthcare Providers.
Elke LootsJosée LeysShara ProostManuel MorrensInge GlazemakersTinne DillesBart Van RompaeyPublished in: International journal of environmental research and public health (2022)
All stakeholders were positive towards medication self-management under specific conditions. According to the participants, medication self-management offered many benefits, including the implementation of more structure for the patient, an ameliorated preparatory phase towards discharge, and an actual improvement of future adherence. All participants considered medication self-management to contribute to more profound medication knowledge and an overall improvement of their health literacy. Implications and future perspectives: These findings will be used to develop a medication self-management tool in hospitalised patients with schizophrenia or bipolar disorders.
Keyphrases
- healthcare
- bipolar disorder
- adverse drug
- primary care
- end stage renal disease
- ejection fraction
- chronic kidney disease
- type diabetes
- prognostic factors
- major depressive disorder
- newly diagnosed
- adipose tissue
- health information
- autism spectrum disorder
- metabolic syndrome
- current status
- patient reported outcomes
- social media